What is the recommended dose of Valtrex (valacyclovir) for treating shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valacyclovir Dosing for Shingles Treatment

The recommended dose of Valtrex (valacyclovir) for treating shingles (herpes zoster) is 1 gram three times daily for 7 days. 1

Dosing Details and Administration

  • Treatment should be initiated at the earliest sign or symptom of herpes zoster
  • Most effective when started within 48 hours of the onset of rash 1
  • Take with or without food 1
  • Continue treatment until all lesions have completely crusted over 2
  • If lesions are not completely crusted after the initial 7-day course, extending treatment is appropriate 2

Dosage Adjustments for Renal Impairment

Valacyclovir dosage must be adjusted based on creatinine clearance:

Creatinine Clearance (mL/min) Valacyclovir Dosing
≥50 (normal) No adjustment needed
30-49 No adjustment needed
10-29 500 mg every 24 hours
<10 500 mg every 24 hours

2

Clinical Evidence

The FDA-approved dosing of 1 gram three times daily for 7 days is based on clinical trials showing this regimen effectively treats herpes zoster. In a large comparative study, valacyclovir (1000 mg three times daily for 7 days) was at least as effective as acyclovir (800 mg five times daily for 7 days) in controlling acute herpes zoster symptoms. Importantly, valacyclovir alleviated zoster-associated pain and postherpetic neuralgia significantly faster than acyclovir 3.

A randomized, double-blind, multicenter study demonstrated that valacyclovir 1000 mg three times daily for 7 days significantly accelerated the resolution of herpes zoster-associated pain compared with acyclovir (median pain durations were 38 days versus 51 days for acyclovir) 4.

Alternative Dosing Regimens

Some research has explored alternative dosing regimens:

  • Valacyclovir 1.5 g twice daily for 7 days has been studied and found to be safe and effective for uncomplicated herpes zoster in immunocompetent patients 5
  • However, the FDA-approved regimen remains 1 gram three times daily for 7 days 1

Special Populations

Immunocompromised Patients

  • Higher doses and longer treatment durations may be necessary
  • Treatment should continue until complete healing of lesions 2
  • For HIV-infected patients with CD4+ count ≥100 cells/mm³, higher doses of oral antivirals may be necessary 2

Children

  • For children under 18 years, dosing is weight-based
  • For chickenpox in immunocompetent children aged 2 to <18 years: 20 mg/kg three times daily for 5 days (not to exceed 1 gram three times daily) 1

Treatment Timing and Duration

  • Initiate treatment at the earliest sign or symptom of herpes zoster 1
  • Continue until all lesions are completely crusted over 2
  • A 14-day regimen showed no significant advantage over the 7-day regimen in clinical studies 3

Important Considerations

  • Patient should remain in isolation until all lesions are completely crusted over to prevent transmission 2
  • Starting treatment later than 72 hours after rash onset may still provide benefit, but valacyclovir should ideally be given as soon as possible after symptoms appear 3
  • Common side effects include nausea and headache 3

By following these dosing recommendations, patients with herpes zoster can experience faster resolution of symptoms and reduced risk of postherpetic neuralgia, significantly improving morbidity and quality of life outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.